Caricamento...
P-022. Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
INTRODUCTION: The development of new pangenotypic direct-acting antivirals (pDAA) against hepatitis C virus (HCV) is revolutionizing the treatment of chronic hepatitis C (CHC). The availability of pDAA provides the opportunity to maximize Sustained Virologic Response and minimize side effects and dr...
Salvato in:
| Pubblicato in: | Turk J Gastroenterol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Turkish Society of Gastroenterology
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021028/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.28 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|